BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 12941803)

  • 1. Pancreatic beta-cell-specific ablation of the multiple endocrine neoplasia type 1 (MEN1) gene causes full penetrance of insulinoma development in mice.
    Bertolino P; Tong WM; Herrera PL; Casse H; Zhang CX; Wang ZQ
    Cancer Res; 2003 Aug; 63(16):4836-41. PubMed ID: 12941803
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gene expression profiling in insulinomas of Men1 beta-cell mutant mice reveals early genetic and epigenetic events involved in pancreatic beta-cell tumorigenesis.
    Fontanière S; Tost J; Wierinckx A; Lachuer J; Lu J; Hussein N; Busato F; Gut I; Wang ZQ; Zhang CX
    Endocr Relat Cancer; 2006 Dec; 13(4):1223-36. PubMed ID: 17158767
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alpha cell-specific Men1 ablation triggers the transdifferentiation of glucagon-expressing cells and insulinoma development.
    Lu J; Herrera PL; Carreira C; Bonnavion R; Seigne C; Calender A; Bertolino P; Zhang CX
    Gastroenterology; 2010 May; 138(5):1954-65. PubMed ID: 20138042
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A mouse model of multiple endocrine neoplasia, type 1, develops multiple endocrine tumors.
    Crabtree JS; Scacheri PC; Ward JM; Garrett-Beal L; Emmert-Buck MR; Edgemon KA; Lorang D; Libutti SK; Chandrasekharappa SC; Marx SJ; Spiegel AM; Collins FS
    Proc Natl Acad Sci U S A; 2001 Jan; 98(3):1118-23. PubMed ID: 11158604
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pancreatic insulinomas in multiple endocrine neoplasia, type I knockout mice can develop in the absence of chromosome instability or microsatellite instability.
    Scacheri PC; Kennedy AL; Chin K; Miller MT; Hodgson JG; Gray JW; Marx SJ; Spiegel AM; Collins FS
    Cancer Res; 2004 Oct; 64(19):7039-44. PubMed ID: 15466197
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Menin promotes the Wnt signaling pathway in pancreatic endocrine cells.
    Chen G; A J; Wang M; Farley S; Lee LY; Lee LC; Sawicki MP
    Mol Cancer Res; 2008 Dec; 6(12):1894-907. PubMed ID: 19074834
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Deregulation of anti-Mullerian hormone/BMP and transforming growth factor-beta pathways in Leydig cell lesions developed in male heterozygous multiple endocrine neoplasia type 1 mutant mice.
    Hussein N; Lu J; Casse H; Fontanière S; Morera AM; Guittot SM; Calender A; Di Clemente N; Zhang CX
    Endocr Relat Cancer; 2008 Mar; 15(1):217-27. PubMed ID: 18310289
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The role and mechanism of high expression of cyclin B2 in MEN1 insulinoma].
    Wu T; Huang XH
    Sheng Li Xue Bao; 2011 Dec; 63(6):555-64. PubMed ID: 22193451
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alterations in gene expression in MEN1-associated insulinoma development.
    Serewko-Auret MM; Mould AW; Loffler KA; Duncan R; Kay GF; Hayward NK
    Pancreas; 2010 Nov; 39(8):1140-6. PubMed ID: 20531244
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumour suppressor menin is essential for development of the pancreatic endocrine cells.
    Fontanière S; Duvillié B; Scharfmann R; Carreira C; Wang ZQ; Zhang CX
    J Endocrinol; 2008 Nov; 199(2):287-98. PubMed ID: 18772165
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of p27(Kip1) expression in insulinomas developed in pancreatic beta-cell specific Men1 mutant mice.
    Fontanière S; Casse H; Bertolino P; Zhang CX
    Fam Cancer; 2006; 5(1):49-54. PubMed ID: 16528608
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanisms of disease: multiple endocrine neoplasia type 1-relation to chromatin modifications and transcription regulation.
    Dreijerink KM; Höppener JW; Timmers HM; Lips CJ
    Nat Clin Pract Endocrinol Metab; 2006 Oct; 2(10):562-70. PubMed ID: 17024155
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Insulinomatosis: a multicentric insulinoma disease that frequently causes early recurrent hyperinsulinemic hypoglycemia.
    Anlauf M; Bauersfeld J; Raffel A; Koch CA; Henopp T; Alkatout I; Schmitt A; Weber A; Kruse ML; Braunstein S; Kaserer K; Brauckhoff M; Dralle H; Moch H; Heitz PU; Komminoth P; Knoefel WT; Perren A; Klöppel G
    Am J Surg Pathol; 2009 Mar; 33(3):339-46. PubMed ID: 19011561
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Heterozygous Men1 mutant mice develop a range of endocrine tumors mimicking multiple endocrine neoplasia type 1.
    Bertolino P; Tong WM; Galendo D; Wang ZQ; Zhang CX
    Mol Endocrinol; 2003 Sep; 17(9):1880-92. PubMed ID: 12819299
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multiple microvascular alterations in pancreatic islets and neuroendocrine tumors of a Men1 mouse model.
    Chu X; Gao X; Jansson L; Quach M; Skogseid B; Barbu A
    Am J Pathol; 2013 Jun; 182(6):2355-67. PubMed ID: 23583653
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Haploinsufficient and predominant expression of multiple endocrine neoplasia type 1 (MEN1)-related genes, MLL, p27Kip1 and p18Ink4C in endocrine organs.
    Taguchi R; Yamada M; Horiguchi K; Tomaru T; Ozawa A; Shibusawa N; Hashimoto K; Okada S; Satoh T; Mori M
    Biochem Biophys Res Commun; 2011 Nov; 415(2):378-83. PubMed ID: 22037578
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reexpression of oncoprotein MafB in proliferative β-cells and Men1 insulinomas in mouse.
    Lu J; Hamze Z; Bonnavion R; Herath N; Pouponnot C; Assade F; Fontanière S; Bertolino P; Cordier-Bussat M; Zhang CX
    Oncogene; 2012 Aug; 31(31):3647-54. PubMed ID: 22120711
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High incidence of mammary intraepithelial neoplasia development in Men1-disrupted murine mammary glands.
    Seigne C; Auret M; Treilleux I; Bonnavion R; Assade F; Carreira C; Goddard-Léon S; Lavergne E; Chabaud S; Garcia A; Mazoyer S; Lu J; Bachelot T; Frappart L; Zhang CX
    J Pathol; 2013 Mar; 229(4):546-58. PubMed ID: 23180448
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Accelerated proliferation and differential global gene expression in pancreatic islets of five-week-old heterozygous Men1 mice: Men1 is a haploinsufficient suppressor.
    Lejonklou MH; Barbu A; Stålberg P; Skogseid B
    Endocrinology; 2012 Jun; 153(6):2588-98. PubMed ID: 22492302
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The multiple endocrine neoplasia type 1 gene product, menin, inhibits insulin production in rat insulinoma cells.
    Sayo Y; Murao K; Imachi H; Cao WM; Sato M; Dobashi H; Wong NC; Ishida T
    Endocrinology; 2002 Jun; 143(6):2437-40. PubMed ID: 12021209
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.